ChartMill assigns a fundamental rating of 2 / 10 to MNLO.
ChartMill assigns a valuation rating of 1 / 10 to Menlo Therapeutics Inc (MNLO). This can be considered as Overvalued.
Menlo Therapeutics Inc (MNLO) has a profitability rating of 0 / 10.
The dividend rating of Menlo Therapeutics Inc (MNLO) is 0 / 10 and the dividend payout ratio is 0%.